A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A new analysis of Global Burden of Disease (GBD) 2021 data highlights major state-by-state differences in rheumatoid arthritis burden, with older adults, women, and high-smoking states bearing the greatest health impact.
A new analysis of Global Burden of Disease (GBD) 2021 data highlights major state-by-state differences in rheumatoid arthritis burden, with older adults, women, and high-smoking states bearing the greatest health impact.
The European Alliance of Associations for Rheumatology (EULAR) updated its 2019 guideline for the management of psoriatic arthritis to integrate new data and therapies.
The European Alliance of Associations for Rheumatology (EULAR) updated its 2019 guideline for the management of psoriatic arthritis to integrate new data and therapies.
A first biologic disease-modifying antirheumatic drug showed similar efficacy among psoriatic arthritis patients with a low number of affected joints as among those with a high number.
A first biologic disease-modifying antirheumatic drug showed similar efficacy among psoriatic arthritis patients with a low number of affected joints as among those with a high number.